• LINC00942, MSI2, and Cisplatin Resistance in Gastric Cancer

  2026-08-31

  The reference study identifies LINC00942 as a chemoresistance-associated lncRNA that stabilizes MSI2 by preventing SCFβ-TrCP-mediated degradation, thereby sustaining m6A-dependent c-Myc mRNA stability. Its integrated molecular and in vivo experiments define a regulatory route linking lncRNA expression, protein turnover, RNA modification, stemness, and cisplatin response in gastric cancer.

• Gallein for GPCR Signaling Research

  2026-08-31

  Gallein is a practical G protein βγ subunit inhibitor for dissecting GPCR-linked signaling in cancer, immune, cardiac, and emerging metabolic assays. This guide translates published use cases into controlled workflows while showing how the lactate-GPR81/FARP1 study can inspire, but not replace, direct validation of Gβγ-dependent mechanisms.

• Biotin-Tyramide for Spatial Senescence Validation

  2026-08-30

  Biotin-tyramide provides enzyme-mediated signal amplification for testing how PURPL, H3K9me3, and senescence markers are organized in cells and tissues. This guide presents a spatial assay strategy that connects the 2025 PURPL study with practical IHC and ISH decisions.

• SM-164 and the New Logic of Apoptotic Signaling

  2026-08-29

  SM-164 illustrates how targeted IAP antagonism can convert apoptotic competence into a measurable, mechanism-led research strategy. When viewed alongside recent evidence that RNA Pol II loss activates active death signaling rather than passive transcriptional collapse, it offers translational researchers a framework for separating pathway engagement from nonspecific cytotoxicity.

• STING agonist-1: B-Cell and TLS Workflows

  2026-08-28

  Build controlled STING pathway activation assays that connect innate immune signaling with B-cell activation, IRF4 biology, and tertiary lymphoid structure research. This practical guide covers dosing, orthogonal readouts, assay controls, and troubleshooting for translational cancer immunology workflows.

• LY2228820: A Practical p38 MAPK Assay Strategy

  2026-08-28

  LY2228820 is a selective p38 MAP kinase inhibitor for dissecting inflammatory, stress-response, and tumor-associated signaling. This guide connects proximal phospho-MK2 measurements with multiomics-informed assay design while defining practical controls, formulation considerations, and experimental limits.

• PTEN mRNA Assay Design for Resistance Models

  2026-08-27

  EZ Cap™ Human PTEN mRNA (ψUTP) supports controlled PTEN restoration in mammalian cancer research. This guide focuses on assay architecture, delivery-aware controls, and interpretation of PI3K/Akt pathway inhibition rather than repeating standard product descriptions.

• Cytochalasin B for Actin-Dependent Entry Assays

  2026-08-27

  Cytochalasin B, also known as NSC 107658, provides a reversible way to test whether actin remodeling is required for pathogen entry, motility, division, or transport. This workflow translates findings from Drosophila S2 infection biology into controlled, concentration-responsive assays for cytoskeletal research and early drug discovery.

• KPT-330 Inhibits Osteoclastogenesis in Osteoarthritis

  2026-08-26

  A 2026 iScience study shows that KPT-330, also known as Selinexor, protects against osteoarthritis progression in a DMM mouse model by suppressing subchondral bone osteoclastogenesis. The work connects XPO1/CRM1-mediated nuclear export with NF-κB and MAPK signaling, providing a mechanistic basis for studying nuclear export inhibition in bone-cartilage disease.

• Cy3 Goat Anti-Mouse IgG (H+L) Antibody Workflow

  2026-08-26

  Translate renalase–PMCA4b findings into practical immunofluorescence, western blot, flow cytometry, and tissue-staining workflows with a sensitive mouse IgG detection antibody. The guide emphasizes signal amplification, assay controls, storage discipline, and troubleshooting for reproducible pathway mapping.

• Tβ4, Notch/NF-κB, and Angiogenesis in Limb Ischemia

  2026-08-25

  The reference study shows that thymosin-β4 promotes endothelial activity and angiogenic remodeling in critical limb ischemia through coordinated Notch and NF-κB pathway regulation. Its combination of gain-of-function experiments with DAPT and NF-κB inhibition provides a useful preclinical framework for testing pathway-dependent vascular repair.

• D-Lin-MC3-DMA for Reliable RNA Assays

  2026-08-25

  A scenario-based guide to using D-Lin-MC3-DMA (SKU A8791) in RNA-delivery workflows linked to cell viability, proliferation, and cytotoxicity testing. It explains formulation compatibility, N/P optimization, assay controls, data interpretation, and practical vendor-selection criteria using published and product-dossier evidence.

• Olsalazine Sodium: Transport-Aware Assay Design

  2026-08-24

  Olsalazine Sodium is a mesalamine dimer with applications in inflammation and colorectal cancer research. This article develops a transport-aware framework that connects xenobiotic clearance findings in Aedes aegypti with better exposure control, endpoint selection, and interpretation in cancer assays.

• Ceruletide Workflows for Pancreatic Fibrosis Research

  2026-08-24

  Use Ceruletide, also known as Caerulein, as a controlled CCK-receptor stimulus for pancreatic injury, secretion, and motility experiments. This guide connects practical peptide handling with fibrosis assays inspired by UCMSC extracellular vesicles and MFGE8 nanoparticle research.

• Fluorescein TSA Fluorescence System Kit Workflow

  2026-08-23

  Turn weak protein, transcript, and signaling readouts into spatially resolved fluorescence with a practical tyramide signal amplification workflow. This guide connects the Fluorescein TSA Fluorescence System Kit to BMP4/SMAD studies in corticotroph PitNET models while emphasizing controls, optimization, and quantitative imaging.

595 records 9/40 page Previous Next First page 上5页 678910 下5页 Last page